OLEMA PHARMACEUTICALS INC. - COMMON STOCK

Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study

11 مايو 2023 08:43:20 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update

09 مايو 2023 16:01:03 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual Congress

08 مايو 2023 07:06:10 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 مايو 2023 16:30:57 بحسب Nasdaq GlobeNewswire

Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual Conference

13 أبريل 2023 16:30:48 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 أبريل 2023 16:30:50 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Strategic Update

09 مارس 2023 16:00:17 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 مارس 2023 17:00:11 بحسب Nasdaq GlobeNewswire

Olema Oncology to Present at Oppenheimer 33rd Annual Healthcare Conference

02 مارس 2023 16:05:19 بحسب Nasdaq GlobeNewswire

Olema Oncology to Participate at Upcoming Investor Conferences

21 فبراير 2023 16:30:35 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 فبراير 2023 18:00:40 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 يناير 2023 16:30:01 بحسب Nasdaq GlobeNewswire

Olema Oncology to Present at 41st Annual J.P. Morgan Healthcare Conference

03 يناير 2023 07:00:58 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces OP-1250 Demonstrates Attractive Combinability with CDK 4/6 Inhibitor Palbociclib in Phase 1b Dose Escalation Study

07 ديسمبر 2022 15:37:49 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 ديسمبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Poster Presentations at the 2022 San Antonio Breast Cancer Symposium (SABCS)

21 نوفمبر 2022 09:16:07 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Third Quarter 2022 Financial Results and Provides Corporate Update

08 نوفمبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 نوفمبر 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Olema Oncology to Present at Upcoming Investor Conferences in November

01 نوفمبر 2022 08:00:02 بحسب Nasdaq GlobeNewswire

Olema Oncology Announces Complete ER Antagonist OP-1250 Continues to Demonstrate Robust Activity in Phase 1/2 Clinical Trial

26 أكتوبر 2022 03:00:00 بحسب Nasdaq GlobeNewswire